|
J Biol Chem, Vol. 274, Issue 27, 18965-18972, July 2, 1999
Mechanism of Endoplasmic Reticulum Retention of Mutant
Vasopressin Precursor Caused by a Signal Peptide Truncation Associated
with Diabetes Insipidus
Nicole
Beuret ,
Jonas
Rutishauser¶,
Marc D.
Bider , and
Martin
Spiess
From the Biozentrum, University of Basel,
Klingelbergstrasse 70, CH-4056 Basel, Switzerland and
¶ Department of Medicine, Kantonsspital, CH-6000
Luzern 16, Switzerland
Autosomal dominant neurohypophyseal diabetes
insipidus is caused by mutations in the gene encoding the vasopressin
precursor protein, prepro-vasopressin-neurophysin II. We analyzed the
molecular consequences of a mutation ( G227) recently identified in a
Swiss kindred that destroys the translation initiation codon. In COS-7 cells transfected with the mutant cDNA, translation was found to
initiate at an alternative ATG, producing a truncated signal sequence
that was functional for targeting and translocation but was not cleaved
by signal peptidase. The mutant precursor was completely retained
within the endoplasmic reticulum. The uncleaved signal did not affect
folding of the neurophysin portion of the precursor, as determined by
its protease resistance. However, formation of disulfide-linked
aggregates indicated that it interfered with the formation of the
disulfide bond in vasopressin, most likely by blocking its insertion
into the hormone binding site of neurophysin. Preventing disulfide
formation in the vasopressin nonapeptide by mutation of cysteine 6 to
serine was shown to be sufficient to cause aggregation and retention.
These results indicate that the G227 mutation induces translation of
a truncated signal sequence that cannot be cleaved but prevents correct
folding and oxidation of vasopressin, thereby causing precursor
aggregation and retention in the endoplasmic reticulum.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Bouligand, C. Ghervan, J. A. Tello, S. Brailly-Tabard, S. Salenave, P. Chanson, M. Lombes, R. P. Millar, A. Guiochon-Mantel, and J. Young
Isolated Familial Hypogonadotropic Hypogonadism and a GNRH1 Mutation
N. Engl. J. Med.,
June 25, 2009;
360(26):
2742 - 2748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm
Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice
Invest. Ophthalmol. Vis. Sci.,
January 1, 2005;
46(1):
223 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Christensen, C. Siggaard, T. J. Corydon, G. L. Robertson, N. Gregersen, L. Bolund, and S. Rittig
Differential Cellular Handling of Defective Arginine Vasopressin (AVP) Prohormones in Cells Expressing Mutations of the AVP Gene Associated with Autosomal Dominant and Recessive Familial Neurohypophyseal Diabetes Insipidus
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4521 - 4531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bonapace, A. Waheed, G. N. Shah, and W. S. Sly
Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17
PNAS,
August 17, 2004;
101(33):
12300 - 12305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu and D. Vollrath
Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma
Hum. Mol. Genet.,
June 1, 2004;
13(11):
1193 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Friberg, M. Spiess, and J. Rutishauser
Degradation of Wild-type Vasopressin Precursor and Pathogenic Mutants by the Proteasome
J. Biol. Chem.,
May 7, 2004;
279(19):
19441 - 19447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beuret, H. Stettler, A. Renold, J. Rutishauser, and M. Spiess
Expression of Regulated Secretory Proteins Is Sufficient to Generate Granule-like Structures in Constitutively Secreting Cells
J. Biol. Chem.,
May 7, 2004;
279(19):
20242 - 20249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Rebello, R. Ramesar, A. Vorster, L. Roberts, L. Ehrenreich, E. Oppon, D. Gama, S. Bardien, J. Greenberg, G. Bonapace, et al.
Apoptosis-inducing signal sequence mutation in carbonic anhydrase IV identified in patients with the RP17 form of retinitis pigmentosa
PNAS,
April 27, 2004;
101(17):
6617 - 6622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Wahlstrom, M. J. Fowler, W. E. Nicholson, and W. J. Kovacs
A Novel Mutation in the Preprovasopressin Gene Identified in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1963 - 1968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ozisik, G. Mantovani, J. C. Achermann, L. Persani, A. Spada, J. Weiss, P. Beck-Peccoz, and J. L. Jameson
An Alternate Translation Initiation Site Circumvents an Amino-Terminal DAX1 Nonsense Mutation Leading to a Mild Form of X-Linked Adrenal Hypoplasia Congenita
J. Clin. Endocrinol. Metab.,
January 1, 2003;
88(1):
417 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Anjos, A. Nguyen, H. Ounissi-Benkalha, M.-C. Tessier, and C. Polychronakos
A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele
J. Biol. Chem.,
November 22, 2002;
277(48):
46478 - 46486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rittig, C. Siggaard, M. Ozata, I. Yetkin, N. Gregersen, E. B. Pedersen, and G. L. Robertson
Autosomal Dominant Neurohypophyseal Diabetes Insipidus due to Substitution of Histidine for Tyrosine2 in the Vasopressin Moiety of the Hormone Precursor
J. Clin. Endocrinol. Metab.,
July 1, 2002;
87(7):
3351 - 3355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Leonardi, P. Vito, C. Mauro, F. Pacifico, L. Ulianich, E. Consiglio, S. Formisano, and B. Di Jeso
Endoplasmic Reticulum Stress Causes Thyroglobulin Retention in this Organelle and Triggers Activation of Nuclear Factor-{kappa}B Via Tumor Necrosis Factor Receptor-Associated Factor 2
Endocrinology,
June 1, 2002;
143(6):
2169 - 2177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Mahoney, E. Weinberger, C. Bryant, M. Ito, J. L. Jameson, and M. Ito
Effects of Aging on Vasopressin Production in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus Due to the {Delta}E47 Neurophysin Mutation
J. Clin. Endocrinol. Metab.,
February 1, 2002;
87(2):
870 - 876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nijenhuis, E. L. T. van den Akker, R. Zalm, A. A. M. Franken, A. P. Abbes, H. Engel, D. de Wied, and J. P. H. Burbach
Familial Neurohypophysial Diabetes Insipidus in a Large Dutch Kindred: Effect of the Onset of Diabetes on Growth in Children and Cell Biological Defects of the Mutant Vasopressin Prohormone
J. Clin. Endocrinol. Metab.,
July 1, 2001;
86(7):
3410 - 3420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chan, M. S. P. Ho, and K. S. E. Cheah
Aberrant Signal Peptide Cleavage of Collagen X in Schmid Metaphyseal Chondrodysplasia. IMPLICATIONS FOR THE MOLECULAR BASIS OF THE DISEASE
J. Biol. Chem.,
March 9, 2001;
276(11):
7992 - 7997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Eubanks, T. L. Nguyen, R. Deeb, A. Villafania, A. Alfadhli, and E. Breslow
Effects of Diabetes Insipidus Mutations on Neurophysin Folding and Function
J. Biol. Chem.,
August 3, 2001;
276(32):
29671 - 29680.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|